Company Overview Financial Statements Notice Statutory Reports 31 Rudolf Atul Chemicals Ltd | Annual Report 2020-21 VII. Others: a. Dr Rao will be entitled to compensation not exceeding six months of basic pay by way of reimbursement of 20% to Atul Ltd. b. In the event of any dispute or difference arising out of this agreement between the parties, such dispute or difference will be referred to arbitration in accordance with the provisions of the Arbitration and Conciliation Act, 1996 or any statutory modification or substitute thereof and all the provisions of that Act so far as are applicable or of any of them for the time being in force will apply to every reference thereof. The venue of the arbitration will be courts at Valsad only. c. Both the parties agree for exclusive jurisdiction of courts at Valsad only. The Board considers that his associationwill be of immense benefit to the Company. Accordingly, the Board recommends the Resolution in item number 4 in relation to reappointment of Dr Rao as the Managing Director from August 18, 2021, to March 13, 2023, for the approval by the Members. Memorandum of interest The nature of the concern or interest of Dr Rao, Managing Director, is that the above Resolution pertains to his agreement with the Company and he will be receiving the remuneration as stated therein, if approved. None of the other Directors or Key Managerial Personnel of the Company and their relatives are concerned or interested, financially or otherwise, in the said Resolution. Registered office: By order of the Board of Directors B | 18598, Survey number 33 Atul 396 020, Gujarat (Rakesh Pathak) India Company Secretary Corporate identity number: U24110GJ2005PLC045564 April 23, 2021
RkJQdWJsaXNoZXIy MjA2MDI2